TipRanks
Go Ultimate55% OFF

Kovai Medical Center & Hospital Ltd. (KOVAI) AI Stock Analysis

Top Page

IN:KOVAI

Kovai Medical Center & Hospital Ltd.

(NSE:KOVAI)

Select Model
Rating:70Outperform
Price Target:INR 6,824.00â–²(17.48% Upside)
Action:reiterated
Date:09/16/26

The score is primarily driven by solid financial performance (steady growth, healthy profitability, and strong operating cash flow) and supportive technical trend signals (price above key moving averages with positive momentum). This is offset by less attractive valuation (P/E ~26.9 and very low dividend yield) and financial variability risks from margin pressure and uneven free cash flow.

Positive Factors
Steady revenue growth and profitabilitySteady revenue expansion alongside a healthy net margin indicates continued demand for KMCH’s tertiary healthcare services and an established operating base. If maintained, this combination can support reinvestment in clinical capacity, diagnostics, and specialty offerings while strengthening earnings over the next several quarters.
Negative Factors
Margin volatilityInconsistent profit scaling suggests that revenue growth is not translating reliably into stronger operating leverage. Persistent cost pressure or changes in service mix could constrain future margin expansion, making earnings growth less durable and increasing sensitivity to execution and pricing conditions.

Kovai Medical Center & Hospital Ltd. (KOVAI) vs. iShares MSCI India ETF (INDA)

-20%-15%-10%-5%0%5%IN:KOVAI-4.79%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 79.52B
Dividend Yield
0.26%
Average Volume (3M)
759
Price to Earnings (P/E)
25.2
Beta (1Y)
0.50
Revenue Growth
14.96%
EPS Growth
14.62%
Country
India
Employees
6,885
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Kovai Medical Center & Hospital Ltd. Business Overview & Revenue Model

Company Description

Kovai Medical Center and Hospital Limited, founded in 1985 and based in Coimbatore, India, provides a comprehensive suite of hospital and educational services. The company operates through two primary divisions: Healthcare Services and Education Serv...

How the Company Makes Money

KOVAI primarily makes money by delivering hospital-based healthcare services and charging patients (or their insurers/employers/government schemes, where applicable) for medical treatment and related services. Key revenue streams typically include: (...

Kovai Medical Center & Hospital Ltd. Financial Statement Overview

Summary

Strong and improving operating cash flow and steady revenue growth support the score, alongside solid profitability and a strengthening equity base. The score is tempered by margin volatility (profits not scaling consistently with revenue) and choppy free cash flow, including a negative year, which adds uncertainty to near-term return capacity.

Income Statement

78Positive

Balance Sheet

74Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue16.42B15.86B13.71B12.20B10.19B9.04B
Gross Profit7.47B5.01B4.63B6.23B7.36B6.48B
EBITDA4.87B4.67B4.08B3.62B2.88B2.72B
Net Income2.53B2.44B2.09B1.80B1.16B1.04B
Balance Sheet
Total Assets020.66B18.00B14.38B14.42B13.43B
Cash, Cash Equivalents and Short-Term Investments3.45B3.47B2.71B2.08B2.47B1.96B
Total Debt04.03B4.15B3.10B5.11B5.50B
Total Liabilities-13.19B7.47B7.14B5.50B7.23B7.33B
Stockholders Equity13.19B13.19B10.86B8.89B7.19B6.09B
Cash Flow
Free Cash Flow01.02B-294.49M2.06B1.36B1.63B
Operating Cash Flow03.54B3.24B3.44B2.63B2.62B
Investing Cash Flow0-2.51B-3.52B-1.38B-1.27B-990.95M
Financing Cash Flow0-295.91M913.67M-2.43B-857.03M-1.19B

Kovai Medical Center & Hospital Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price5808.45

Price Trends

50DMA6008.00Negative
100DMA5959.07Negative
200DMA5661.48Positive

Market Momentum

MACD-48.73Negative
RSI40.78Neutral
STOCH59.82Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KOVAI, the sentiment is Negative. The current price of 5808.45 is below the 20-day moving average (MA) of 5891.89, below the 50-day MA of 6008.00, and above the 200-day MA of 5661.48, indicating a neutral trend. The MACD of -48.73 indicates Negative momentum. The RSI at 40.78 is Neutral, neither overbought nor oversold. The STOCH value of 59.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KOVAI.

Kovai Medical Center & Hospital Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:KOVAI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:ARTEMISMEDIN:ARTEMISMED80OutperformINR 46.26B38.38―0.15%14.96%20.76%
IN:YATHARTHIN:YATHARTH75OutperformINR 89.42B49.30―0.05%44.00%24.10%
IN:INDRAMEDCOIN:INDRAMEDCO71OutperformINR 27.97B14.90―1.31%10.92%12.12%
IN:KOVAIIN:KOVAI70OutperformINR 63.56B25.16―0.26%14.96%14.62%
IN:JLHLIN:JLHL59NeutralINR 84.02B45.27―0.08%16.71%-6.09%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:SHALBYIN:SHALBY43NeutralINR 13.06B34.08――6.50%―

* General Sector Average

Performance Comparison

-50%-25%0%25%IN:KOVAIIN:ARTEMISMEDIN:INDRAMEDCOIN:JLHLIN:SHALBYIN:YATHARTHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:KOVAI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:KOVAIKovai Medical Center & Hospital Ltd.5808.45-511.56-8.09%
IN:ARTEMISMEDArtemis Medicare Services Ltd.292.2047.6619.49%
IN:INDRAMEDCOIndraprastha Medical Corporation Limited305.15-263.62-46.35%
IN:JLHLJupiter Life Line Hospitals Ltd.256.30-57.49-18.32%
IN:SHALBYShalby Ltd.120.90-123.30-50.49%
IN:YATHARTHYatharth Hospital and Trauma Care Services Limited928.05114.3314.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 15, 2026